相关实验视频
Updated: Jul 24, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.5K
小儿科的库辛病:一个更新.
Marcio José Concepción-Zavaleta1, Cristian David Armas2, Juan Eduardo Quiroz-Aldave3
1Universidad Cientifica del Sur, Lima, Perú.
Annals of pediatric endocrinology & metabolism
|July 4, 2023
概括
由于垂体腺瘤引起的儿童库辛病 (CD) 阻碍了儿童的生长和发育. 早期诊断和治疗对于管理高皮质醇症和改善儿科患者的治疗结果至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 神经内分泌学神经内分泌学
- 在瘤学瘤学.
背景情况:
- 库希病 (CD) 是内源性库希综合征 (CS) 的主要原因,由产生ACTH的垂体腺瘤驱动.
- 在儿科患者中,由于高皮质醇症,CD显著影响生长和发育.
- 儿童中关键的CS症状包括体重增加,面部变化,发,病毒化和.
研究的目的:
- 为儿童群体提供库辛病的全面概述.
- 总结有关儿科CD病理生理学,诊断和治疗的当前知识.
- 突出儿童早期治疗的挑战和重要性.
主要方法:
- 这篇叙事综述综合了有关儿科库辛病的现有文献.
- 它涵盖了诊断标准,包括生物化学测试和病理确认.
- 讨论了手术,药物治疗和放射治疗等治疗方法.
主要成果:
- 诊断确认依赖于建立内源性高皮质醇和ACTH依赖,其次是病理.
- 治疗的目的是使皮质醇水平正常化,并缓解临床症状和症状.
- 管理策略包括手术,医疗,放射治疗或组合方法.
结论:
- 在儿童中,库希病带来了独特的挑战,因为它对生长和青春期发育的影响.
- 早期诊断和干预对于控制高皮质醇症和优化预后至关重要.
- 儿科CD的罕见性需要增加医生的经验和意识,以有效管理.
更多相关视频
相关概念视频
Adrenal Gland Disorders
1.6K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.6K
Cystic Fibrosis: Management
195
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
195
COPD: Management Using Bronchodilators and Corticosteroids
250
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
250
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Pulmonary Hypertension: Classification and Pathogenesis
231
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
231
Hypoglycemia and Glucagon
305
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
305

